|
0
|
|
Domvanalimab plus zimberelimab in unresectable and immunotherapy refractory biliary tract cancers: a phase 2 trial.
(nature.com)
|
Hsiehchen D
…
Zhu H
Nature Communications
2026-07-21
|
#cancer
#immunotherapy
#clinical trial
#checkpoint-inhibitors
#amr
|
|
0
|
|
Vactosertib plus pembrolizumab in patients with non-microsatellite instability-high metastatic colorectal or gastric cancer: a multicenter, phase Ib/IIa study.
(nature.com)
|
Lee KW
…
Kim TW
Nature Communications
2026-07-21
|
#clinical trial
#immunotherapy
#colorectal
#metastatic
#gastric
|
|
0
|
|
Dalpiciclib plus endocrine therapy in women with HR(+)/HER2(-) advanced breast cancer and visceral crisis: a multicenter, nonrandomized, phase 2 DARVIN trial.
(nature.com)
|
Mo H
…
Ma F
Nature Cancer
2026-07-21
|
#breast cancer
#endocrine therapy
#cdk-inhibitor
#clinical trial
#biomarker
|
|
0
|
|
Pharmacokinetics of injectable favipiravir: phase I, randomized, double-blind, placebo-controlled study in healthy East Asian subjects.
(journals.asm.org)
|
Mikamo H
…
Sakurai T
Antimicrobial Agents and Chemotherapy
2026-07-21
|
#pharmacokinetics
#antiviral
#clinical trial
#bioavailability
|
|
0
|
|
Safety and immunogenicity of an adjuvant-free peptide vaccine targeting IL-17A: Phase 1 randomized controlled trial.
(linkinghub.elsevier.com)
|
Kasahara S
…
Tomita T
iScience
2026-07-21
|
#vaccination
#immunogenicity
#clinical trial
#peptide
#cytokine
|
|
0
|
|
Olorofim in Treatment of Patients With Poorly Controlled Disseminated Coccidioidomycosis : A Single-Group, Open-Label, Phase 2b, Multicenter Study.
(acpjournals.org)
|
Donovan FM
…
Thompson GR 3rd
Annals of Internal Medicine
2026-07-21
|
#coccidioidomycosis
#clinical trial
#antifungal
#infection
#mycosis
|
|
0
|
|
An iPSC-derived neural progenitor cell therapy for subacute spinal cord injury: a phase 1 trial with long-term follow-up.
(nature.com)
|
Sugai K
…
Okano H
Nature Medicine
2026-07-21
|
#spinal cord injury
#ipsc
#stem-cell-therapy
#clinical trial
#neuroregeneration
|